...efficacy data cut-off.The trial is evaluating four dose cohorts of AB680 in combination with Abraxane nab-paclitaxel...

...six months.In 24 evaluable patients in the same study treated with zanidatamab in combination with paclitaxel...

...of the 17 patients.The trial is evaluating four dose cohorts of AB680 in combination with Abraxane nab-paclitaxel...

...eftilagimod alpha in combination with paclitaxel led to a survival benefit of 2.7 months versus paclitaxel...

...regimens: FOLFIRINOX or Gemzar gemcitabine plus Abraxane paclitaxel. It’s...

...SCAC) who have progressed following chemotherapy.  A Phase III trial of retifanlimab with carboplatin and paclitaxel...

...for Athenex’s breast cancer therapyFDA accepted and granted Priority Review to an NDA for oral paclitaxel...

...primary endpoint in the Phase III HIBISCUS I induction study.  Last week Genentech said Tecentriq atezolizumab plus paclitaxel missed...

...Royalty Partners under which it will receive $50 million upon FDA approval of its oral paclitaxel...

...to improve progression-free survival in newly diagnosed advanced ovarian cancer when added to Avastin bevacizumab, paclitaxel...